# Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effectiveness-and-tolerability-of-simvastatin-plus-fenofibrate-for-combined/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Scott M. Grundy,Gloria Lena Vega,Žhong Yuan,Wendy P. Battisti,William E. Brady,Joanne Palmisano |
| Citations | 310 |
| DOI | 10.1016/j.amjcard.2004.10.012 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1988048988 |
| PMID | 15695129 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Žhong Yuan](https://scholariq.org/researchers/zhong-yuan/)
- [Gloria Lena Vega](https://scholariq.org/researchers/gloria-lena-vega/)

## Paper journal

- [The American Journal of Cardiology](https://scholariq.org/journals/the-american-journal-of-cardiology/)

## Paper primary topic

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Paper topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.